Publications by authors named "James Tetrud"

Claim this Profile
L
LRRK2 p.Ile1371Val Mutation in a Case with Neuropathologically Confirmed Multi-System Atrophy.
Kelsey Lee, Khanh-Dung Nguyen, Chao Sun, Mei Liu, Faria Zafar, James W Tetrud

J Parkinsons Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic fine-mapping of the Iowan gene triplication in a patient with Parkinson's disease.
Faria Zafar, Ruksana Azhu Valappil, Sam Kim, Krisztina K Johansen, Anne Lynn S Chang, James W Tetrud

NPJ Parkinsons Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MPTP-induced parkinsonism: an historical case series.
Jorik Nonnekes, Bart Post, James W Tetrud, J William Langston, Bastiaan R Bloem

Lancet Neurol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease.
James Tetrud, Paul Nausieda, David Kreitzman, Grace S Liang, Anette Nieves

J Neurol Sci· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial dysfunction in skin fibroblasts from a Parkinson's disease patient with an alpha-synuclein triplication.
Sally K Mak, Deepika Tewari, James W Tetrud, J William Langston, Birgitt Schüle

J Parkinsons Dis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

JAMA Neurol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's disease.
William G Ondo, Christine Hunter, Stuart H Isaacson, Dee E Silver, R Malcolm Stewart, James W Tetrud

Parkinsonism Relat Disord· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
Kelly E Lyons, Joseph H Friedman, Neal Hermanowicz, Stuart H Isaacson, Robert A Hauser, James W Tetrud

Clin Neuropharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.
Carol Addy, Chris Assaid, David Hreniuk, Mark Stroh, Yang Xu, James Tetrud

J Clin Pharmacol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).
Peter A LeWitt, M Guttman, James W Tetrud, Paul J Tuite, Akihisa Mori

Ann Neurol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing short-term symptom control and long-term functional outcomes in patients with Parkinson's disease.
James W Tetrud

CNS Spectr· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases.
Marjorie A Murphy, Joseph H Friedman, James W Tetrud, Stewart A Factor

J Clin Neurosci· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel formulation of selegiline for the treatment of Parkinson's disease.
James W Tetrud, William C Koller

Neurology· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment challenges in early stage Parkinson's disease.
James Tetrud

Neurol Clin· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rest tremor in rhesus monkeys with MPTP-induced parkinsonism.
Marina E Emborg, James W Tetrud, Jeff Moirano, William W McLaughlin, Krys S Bankiewicz

Front Biosci· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voluntarily simulated tremor in normal subjects.
Pierre R Burkhard, J William Langston, James W Tetrud

Neurophysiol Clin· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis